Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the ...

The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But ...

U.S. President Donald Trump has repeatedly mentioned pharmaceuticals as another industry that could be targeted by tariffs, ...

Ever since the first Drug Price Control Order was announced by the government way back in 1979 to make essential drugs available at affordable prices, overcharging of drug prices by the pharmaceutical ...

The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...

Donald Trump is executing a shock-and-awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ending birthright citizenship, are quickly slapped down in the courts. Some, ...

The National Pharmaceutical Pricing Authority (NPPA) will take action if the pharmacies fail to comply with the diktat, it ...

Currently, the final negotiated price for a drug cannot exceed an upper limit ... The Trump administration would likely "want to take control of that process, where the parties work out an ...